(Korean) 보로노이, 美 바이오社에 6680억 기술 수출- 한국경제 BIO Insight anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2022/12/01 (Korean) 보로노이, 美 피라미드에 1조원 규모 고형암 치료제 기술수출 - 이데일리 anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/11/24 (Korean) 보로노이, 자가면역질환 치료제 3,750억원 규모 기술수출 - 매일경제 anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/10/28 (Korean) 이노엔, 보로노이서 '선택적 RET 저해제' 도입…항암신약 개발 - 한국경제 BIO Insight anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/02/15 JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline JW Pharmaceutical·VORONOI, Joint develpoment of targeting STAT3 in anticancer field - mk.co.krOn December 2, JW Pharmaceutical inked a deal with Korean biotech startup Voronoi to develop next-generation innovative new drugs. It plans to develop a next-generation innovative new drug with global competitiveness by combining JW Pharmaceutical's small molecule anticancer drug candidate of targeting STAT3 with Voronoi's protein decomposition technology 'Protein Degrader(PROTAC; Proteolysis-targeting chimera)'. 기사 전문보기 2021/01/27 (Korean) 보로노이, 美제약사에 폐암 치료제 7200억 기술수출 anemptytextlline anemptytextlline anemptytextlline anemptytextlline anemptytextlline Sorry, this entry is only available in Korean. 2021/01/27